The Valley Desk

NCT01400139 · Interventional trial

Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period.

Overall registry status Completed

Phase 3

Conditions Chronic Nonmalignant and Nonneuropathic Pain

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov